Despite completing DRAP registration and obtaining Cabinet Committee approval, vital cancer and specialty medicines remain legally unavailable across the country
Federal Minister for Commerce Jam Kamal Khan chaired a high-level review, directing Foreign Trade Wings to formulate country-specific plans prioritizing
Pakistan is moving toward WHO Maturity Level-3 accreditation by April 2027—a landmark step announced by Health Minister Syed Mustafa Kamal.
The Cabinet Committee for Drug Pricing, chaired by Finance Minister Muhammad Aurangzeb, has approved Maximum Retail Prices (MRPs) for 52
PPMA presented the pharmaceutical industry’s perspective on key sector issues, including the deregulation of non-essential medicines. The meeting was presided
DRAP has officially issued draft amendments regarding the Drugs Labelling and Packing Rules and is requesting feedback from stakeholders. We
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
